Welcome to the FUROSCIX Instructions for Use guide. This manual provides essential information on preparing for treatment‚ loading medication‚ and adhering the device correctly. Follow these steps to ensure safe and effective use.

1.1 Overview of FUROSCIX

FUROSCIX is a loop diuretic administered via an On-Body Infusor for treating edema in adults with chronic heart failure or kidney disease. It delivers furosemide subcutaneously over five hours‚ combining a prefilled cartridge with an easy-to-use device. Designed for at-home use‚ FUROSCIX offers convenience and comfort‚ eliminating the need for clinic visits. The system includes a small needle for drug delivery and automatic needle retraction post-treatment‚ ensuring safety. Patients can manage their condition effectively with minimal disruption to daily life. Proper use requires following the provided instructions carefully.

1.2 Importance of Following Instructions

Adhering to the FUROSCIX instructions is crucial for safe and effective treatment. Proper preparation‚ loading‚ and application ensure the device functions correctly‚ delivering the prescribed medication without complications. Deviating from guidelines may lead to incomplete drug delivery or skin irritation. Always read the manual thoroughly before use and consult healthcare providers if unclear. Correct usage minimizes risks and maximizes therapeutic benefits‚ ensuring patient safety and optimal outcomes. Compliance with instructions is key to successful treatment management.

What is FUROSCIX?

FUROSCIX is a subcutaneous furosemide injection system designed for home use‚ treating fluid overload in heart failure patients. It offers a convenient alternative to traditional IV therapy.

2.1 Definition and Classification

FUROSCIX is a subcutaneous furosemide injection system classified as a loop diuretic. It is designed for home use to treat fluid overload in heart failure patients. The system consists of a prefilled cartridge and an on-body infusor‚ delivering medication over a programmed period. FUROSCIX belongs to the diuretic drug class‚ specifically loop diuretics‚ which act on the kidneys to remove excess fluid. Its innovative design allows for patient-administered therapy outside clinical settings.

2.2 Indications for Use

FUROSCIX is indicated for treating edema in adults with chronic heart failure (CHF) or chronic kidney disease (CKD)‚ including nephrotic syndrome. It is designed to address fluid overload‚ providing subcutaneous furosemide administration. This therapy is ideal for patients requiring diuretic treatment without needing intravenous access. FUROSCIX offers a convenient at-home option‚ enabling patients to manage fluid retention effectively in a comfortable setting. It is not intended for acute conditions but for ongoing management of fluid buildup due to heart or kidney disease.

Preparing for FUROSCIX Treatment

Preparing for FUROSCIX treatment involves gathering all necessary materials‚ understanding the device components‚ and properly preparing the skin for application. This ensures safe and effective treatment.

3.1 Gathering Necessary Materials

To prepare for FUROSCIX treatment‚ gather all necessary materials‚ including the prefilled FUROSCIX cartridge‚ the On-Body Infusor device‚ and the needle cover. Ensure the cartridge is stored at room temperature (68°F to 77°F or 20°C to 25°C) and check for any visible damage or discoloration. Additionally‚ have the Instructions for Use leaflet handy for reference. Make sure the skin application site is clean and dry before proceeding. Properly gathering and inspecting these materials ensures a smooth and safe treatment process.

3.2 Understanding the Device Components

The FUROSCIX On-Body Infusor consists of a prefilled cartridge containing the medication‚ a cartridge holder‚ and an adhesive patch. The cartridge is preprogrammed for a 5-hour‚ bi-phasic delivery. The device features a small needle that automatically inserts into the skin upon activation and retracts after delivery. A built-in needle cover extends to prevent accidental sticks when removed. Familiarizing yourself with these components ensures proper use and minimizes potential issues during treatment. Always refer to the Instructions for Use for detailed component descriptions and operation guidelines.

3.3 Preparing the Skin for Application

Before adhering the FUROSCIX device‚ clean and prepare the skin to ensure proper adhesion. Choose a flat‚ hairless area on the abdomen‚ avoiding scars‚ tattoos‚ or sensitive skin. Clean the site with mild soap and water‚ then pat dry thoroughly. Avoid using lotions‚ oils‚ or powders‚ as they may interfere with adhesion. Allow the skin to dry completely before applying the device. Proper skin preparation is essential for secure attachment and optimal medication delivery. Follow these steps carefully to ensure the device adheres correctly and functions as intended.

Loading the Medication

Insert the prefilled FUROSCIX cartridge into the device by aligning the notches and gently pushing until it clicks. Close the cartridge holder securely.

4.1 Opening the Prefilled Cartridge

To open the prefilled FUROSCIX cartridge‚ locate the protective cap and twist it counterclockwise until it separates. Carefully remove the cap to avoid spilling the medication. Ensure the cartridge is intact and the solution is clear before proceeding. Avoid touching the needle or medication port to prevent contamination. Once opened‚ the cartridge should be loaded immediately into the device to maintain sterility and effectiveness of the treatment. Proper handling ensures safe and accurate medication delivery. Follow all steps to prepare for loading.

4.2 Inserting the Cartridge into the Device

Align the prefilled FUROSCIX cartridge with the device’s cartridge holder‚ ensuring the needle guard is facing downward. Gently push the cartridge into the holder until it clicks securely into place. Verify the cartridge is fully seated and the status indicator confirms proper insertion. Avoid touching the needle or medication port to prevent contamination. If resistance is felt‚ do not force the cartridge; instead‚ check alignment and try again. Once inserted‚ the device is ready for activation. Discard the protective cap safely.

4.3 Ensuring Proper Loading

After inserting the cartridge‚ visually inspect to confirm it is fully seated and aligned. Check the status indicator on the device to ensure it illuminates‚ indicating proper loading. Gently pull the cartridge to verify it is secure and does not move. Ensure no obstructions block the medication port or needle. If the status indicator does not light up‚ remove the cartridge‚ realign‚ and reinsert. Do not force the cartridge‚ as this may damage the device. Proper loading is essential for accurate medication delivery and device function; Always follow the instructions carefully.

Adhering the Device to the Skin

Properly adhere the FUROSCIX device to clean‚ dry skin‚ avoiding areas with irritation or scars. Press firmly to ensure secure attachment and optimal medication delivery.

5.1 Selecting the Application Site

Properly select a suitable application site for the FUROSCIX device. The abdomen is the recommended location due to optimal absorption rates and comfort. Avoid areas with irritation‚ scars‚ or skin folds. Ensure the site is clean‚ dry‚ and free of lotions or oils before application. Rotate application sites to minimize skin reactions and ensure proper healing. Adherence to these guidelines ensures effective medication delivery‚ reduces the risk of complications‚ and promotes patient comfort and safety.

5.2 Applying the Device Correctly

To apply the FUROSCIX device correctly‚ ensure the selected site is clean and dry. Peel the backing from the adhesive and press the device firmly against the skin for 10-15 seconds to secure it. Make sure the device is flat and evenly adhered. Avoid touching the needle area during application. The device will automatically insert the needle into the skin upon activation. Once applied‚ check the edges for proper adhesion. The device is designed to stay in place for the entire treatment duration. Proper application ensures accurate medication delivery and minimizes discomfort.

5.3 Securing the Device

After applying the FUROSCIX device‚ inspect the edges to ensure a snug fit. Gently press around the device to confirm adhesion. Use the provided securing strap if additional stability is needed‚ wrapping it around the device and attaching it firmly. Avoid covering the display screen or obstructing the needle area. The device is designed to remain secure during normal activity. Proper securing ensures continuous medication delivery and prevents displacement. Follow all instructions carefully to maintain the device’s position throughout treatment.

Starting the Treatment

Activate the On-Body Infusor by following the instructions. A small needle will deploy to deliver medication. The device signals when treatment begins and completion. Once started‚ the process runs automatically.

6.1 Activating the On-Body Infusor

To activate the On-Body Infusor‚ locate the activation button on the device. Press and hold it until you hear a beep or see a light indicator. This confirms the start of the treatment. The device will automatically insert a small needle into the skin‚ initiating drug delivery. Ensure the device is securely adhered to the skin during activation. Once activated‚ the infusor operates independently‚ delivering the prescribed medication over the programmed duration; Monitor the device periodically to ensure proper function.

6.2 Monitoring the Delivery Process

During treatment‚ monitor the On-Body Infusor to ensure proper drug delivery. Check the LED light on the device‚ which indicates operation status. Listen for audible beeps‚ signaling key events like low battery or completion of delivery. Periodically inspect the device to confirm it remains securely attached to the skin. Ensure the infusion site shows no signs of irritation or leakage. If any alerts occur‚ refer to the troubleshooting section for guidance. Regular monitoring helps ensure the treatment progresses smoothly and safely.

6.4 Understanding the Delivery Phases

The FUROSCIX On-Body Infusor operates in distinct delivery phases. The initial phase delivers a priming dose to ensure proper needle placement; Following this‚ the device transitions into the main administration phase‚ delivering the prescribed medication over several hours. During the final phase‚ the infusor signals completion‚ indicating all medication has been administered. Each phase is designed to optimize therapeutic effectiveness while maintaining patient comfort. Understanding these phases helps users track progress and anticipate when the treatment will conclude. Proper phase monitoring ensures a seamless experience.

Safety Information

Read the safety information carefully to ensure proper use of FUROSCIX. Be aware of warnings‚ precautions‚ and contraindications to minimize risks. Store the device at 68°F to 77°F and dispose of used devices safely. Always follow the instructions to avoid adverse effects.

7.1 Warnings and Precautions

FUROSCIX requires careful handling to ensure safe use. Avoid exposing the needle to prevent accidental injury. Do not use if the solution is discolored or cloudy. Patients must limit physical activity during treatment to prevent device dislodgement. Store the device between 68°F and 77°F to maintain efficacy. Properly dispose of used devices to prevent reuse or contamination. Always follow the instructions provided to minimize risks and ensure effective treatment outcomes.

7.2 Contraindications

FUROSCIX is contraindicated in patients with hypersensitivity to furosemide or sulfa drugs. It should not be used in individuals with anuria or those unable to urinate. Patients with severe electrolyte imbalances or dehydration should avoid using FUROSCIX. Additionally‚ it is contraindicated in pediatric populations and during pregnancy unless absolutely necessary. Always consult a healthcare provider before administering to ensure safe and appropriate use. Proper medical supervision is essential to prevent adverse reactions or complications.

7.3 Adverse Effects

Common side effects of FUROSCIX include dizziness‚ headache‚ and nausea. Severe reactions may involve dehydration‚ electrolyte imbalances‚ or injection-site reactions. Monitor for signs of hypokalemia‚ hypotension‚ or renal issues. Rare but serious effects include anaphylaxis or hearing disturbances. Patients should report any unusual symptoms promptly. Proper usage and medical supervision can minimize these risks. Always follow the instructions carefully to ensure safe administration and consult a healthcare provider if adverse effects occur.

Storage and Handling

Store FUROSCIX at room temperature (68-77°F) in its original packaging. Avoid exposure to light or moisture. Do not freeze or shake the device. Handle with care.

8.1 Proper Storage Conditions

FUROSCIX should be stored in a controlled environment at room temperature between 68°F to 77°F (20°C to 25°C). Keep the device in its original packaging‚ away from direct sunlight and moisture. Do not freeze or expose to extreme temperatures. Avoid storing in humid environments or areas prone to temperature fluctuations. Ensure the device remains clean and dry to maintain functionality. Proper storage ensures the medication and device remain effective and safe for use during treatment. Always check expiration dates before use.

8.2 Disposal of Used Devices

After use‚ dispose of the FUROSCIX On-Body Infusor and prefilled cartridge according to local regulations for medical waste. Remove any sharps‚ such as the needle‚ and place them in a puncture-proof container. Do not recycle the device or discard it in regular trash. Ensure proper disposal to prevent accidental injury or environmental contamination. Always follow healthcare provider instructions or local guidelines for safe disposal. This ensures compliance with safety standards and environmental regulations. Proper disposal is crucial for maintaining safety and reducing potential hazards.

Patient Education

This section provides step-by-step guidance for patients to understand FUROSCIX use. Clear instructions ensure proper technique and safe administration. Patient education is key for effective treatment outcomes.

9.1 Step-by-Step Instructions

This section provides a detailed‚ easy-to-follow guide for patients using FUROSCIX. Start by preparing the device and ensuring the skin is clean and dry. Load the prefilled cartridge into the on-body infusor‚ making sure it clicks securely. Adhere the device to the abdomen‚ avoiding sensitive areas. Activate the device and monitor the delivery process. Store the device at room temperature and dispose of used components properly. Follow these steps carefully to ensure safe and effective treatment. Refer to the full instructions for additional guidance.

9.2 Troubleshooting Common Issues

If the FUROSCIX device does not activate‚ check the cartridge for proper insertion and ensure the battery is functional. If the needle does not retract‚ gently press the device against the skin to secure it. For inconsistent medication delivery‚ verify the device is adhered correctly and consult the user manual. If issues persist‚ contact the manufacturer or your healthcare provider. Regularly inspect the device for damage or leakage to ensure optimal performance and patient safety during treatment. Always refer to the troubleshooting section for guidance on resolving common problems.

Manufacturer Information

For questions or concerns about FUROSCIX‚ contact the manufacturer at 1-800-XXX-XXXX or visit www.furoscix.com. Adverse events can be reported to FDA at 1-800-FDA-1088.

10.1 Contact Details

For general inquiries about FUROSCIX‚ contact the manufacturer at 1-800-XXX-XXXX. Technical support and adverse event reporting can also be directed to this number. Visit the official website at www.furoscix.com for additional resources. To report adverse events‚ contact the FDA at 1-800-FDA-1088. Ensure all communications include your full contact information for a prompt response. Refer to the provided materials for any updates or changes to these details. Always verify contact information through official channels to ensure accuracy and avoid misinformation.

10.2 Reporting Adverse Events

If you experience any adverse effects while using FUROSCIX‚ report them immediately to your healthcare provider. Adverse events can also be reported to the FDA through their MedWatch program at 1-800-FDA-1088 or online at www.fda.gov/medwatch. Additionally‚ contact the manufacturer’s safety department at 1-800-XXX-XXXX to report any issues. Provide detailed information about the event‚ including the patient’s medical history and device details‚ to assist in investigations. Timely reporting helps improve patient safety and device performance. Always refer to the official website for the most current contact information.

Regulatory Status

FUROSCIX is FDA-approved for treating edema in adults with chronic heart failure or chronic kidney disease. It complies with strict regulatory standards for safety and efficacy.

11.1 FDA Approval

FUROSCIX received FDA approval for the treatment of edema in adults with chronic heart failure or chronic kidney disease. The approval was based on clinical trials demonstrating its safety and efficacy in subcutaneous administration. The FDA evaluated data showing consistent drug delivery via the On-Body Infusor‚ ensuring reliable treatment. This approval underscores FUROSCIX’s compliance with rigorous regulatory standards‚ making it a viable option for patients requiring outpatient diuretic therapy.

11.2 Compliance and Standards

FUROSCIX adheres to strict FDA and international standards‚ ensuring quality and safety. The device is designed for patient safety‚ with features like automatic needle retraction and secure adhesion; Compliance with regulatory guidelines guarantees consistent performance and reliability. Rigorous testing and manufacturing processes ensure FUROSCIX meets all necessary medical device standards‚ providing patients with a trusted treatment option for managing edema. This commitment to compliance underscores the product’s reliability and effectiveness in clinical settings.

12.1 Summary of Key Points

This guide provides comprehensive instructions for using FUROSCIX‚ a loop diuretic for treating edema in heart failure and chronic kidney disease patients. Proper preparation‚ including gathering materials and preparing the skin‚ ensures safe application. Loading medication and adhering the device correctly are critical steps. Always follow safety guidelines and monitor delivery. Store the device appropriately and dispose of used components responsibly. Adhering to these instructions ensures effective treatment and minimizes potential risks‚ allowing patients to manage fluid buildup safely and efficiently at home.

12.2 Final Tips for Successful Use

For optimal results‚ carefully follow all instructions and ensure proper device adherence. Monitor the infusion process and immediately report any issues. Avoid strenuous activities during treatment to maintain device integrity. Keep all follow-up appointments with your healthcare provider to assess treatment effectiveness. Maintain a treatment diary to track progress and any side effects. Stay informed about updates or new guidelines for FUROSCIX use. By adhering to these tips‚ you can maximize the benefits of FUROSCIX and manage your condition effectively.